Anavex Life Sciences Newsroom

Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment

WSJJan 15 13:50 ET

Anavex Life Sciences Reveals Peer-reviewed Publication Of Oral Blarcamesine Phase IIb/III Data In Journal Of Prevention Of Alzheimer's Disease

BenzingaJan 15 07:34 ET

Express News | Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase Iib/III Data in the Journal of Prevention of Alzheimer’s Disease

ReutersJan 15 07:30 ET

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease

GlobeNewswireJan 15 07:30 ET

Anavex Reports Long-Term Benefits of Blarcamesine in Slowing Early Alzheimer's Disease Progression

BenzingaJan 13 08:36 ET

Express News | D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $46 Price Target

BenzingaJan 13 08:09 ET

Anavex Life Sciences Analyst Ratings

BenzingaJan 13 08:08 ET · Ratings

Express News | Anavex Life Sciences Corp: Blarcamesine Exhibited a Favorable Safety Profile With No Treatment-Related Deaths

ReutersJan 13 07:30 ET

Express News | Anavex Life Sciences Corp: Topline Attention-Ad Trial: Patients Showed Improved Cognition and Function Over Three Years

ReutersJan 13 07:30 ET

Express News | New Phase Iib/III Clinical Data Demonstrates Over Three Years of Continuous Treatment With Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

ReutersJan 13 07:30 ET

Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 07:30 ET

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?

Yahoo FinanceDec 31, 2024 09:40 ET

All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy

Zacks Dec 30, 2024 11:15 ET

Companies Like Anavex Life Sciences (NASDAQ:AVXL) Can Afford To Invest In Growth

Simply Wall StDec 29, 2024 09:23 ET

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 26, 2024 12:35 ET

Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday

BenzingaDec 26, 2024 10:31 ET

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Raises Target Price to $42

Moomoo NewsDec 26, 2024 06:31 ET · Ratings

Anavex Life Sciences: Buy Rating Driven by European Approval Prospects and Strong Financial Position

TipRanksDec 26, 2024 06:15 ET · Ratings

Express News | Anavex Life Sciences Corp. : H.c. Wainwright Raises Target Price to $42 From $40

ReutersDec 26, 2024 06:07 ET

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

Yahoo FinanceDec 25, 2024 07:30 ET